Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Blood Pressure Response and Symptoms During Active Standing Test Among Hospitalized and Outpatients With Heart Failure: Results From the GRAVITY-HF Prospective Observational Cohort Study.
Soloveva A, Fedorova D, Fudim M, Vinogradova N, Chemodanova A, Kozlova A, Fomin I, Skuratova M, Shneidmiller N, Golovina G, Kosmacheva E, Gubareva E, Teterina M, Godunko E, Chesnikova A, Okunev I, Kashtalap V, Kuznetsova M, Dzhioeva O, Kopeva K, Zvartau N, Villevalde S. Soloveva A, et al. Among authors: villevalde s. J Card Fail. 2024 Jan 17:S1071-9164(24)00013-7. doi: 10.1016/j.cardfail.2023.12.017. Online ahead of print. J Card Fail. 2024. PMID: 38242427
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis.
Rossing P, Anker SD, Filippatos G, Pitt B, Ruilope LM, Birkenfeld AL, McGill JB, Rosas SE, Joseph A, Gebel M, Roberts L, Scheerer MF, Bakris GL, Agarwal R; FIDELIO-DKD and FIGARO-DKD Investigators. Rossing P, et al. Diabetes Care. 2022 Dec 1;45(12):2991-2998. doi: 10.2337/dc22-0294. Diabetes Care. 2022. PMID: 35972218 Free PMC article. Clinical Trial.
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis.
Agarwal R, Tu W, Farjat AE, Farag YMK, Toto R, Kaul S, Lawatscheck R, Rohwedder K, Ruilope LM, Rossing P, Pitt B, Filippatos G, Anker SD, Bakris GL; FIDELIO-DKD and FIGARO-DKD Investigators. Agarwal R, et al. Ann Intern Med. 2023 Dec;176(12):1606-1616. doi: 10.7326/M23-1023. Epub 2023 Dec 5. Ann Intern Med. 2023. PMID: 38048573 Clinical Trial.
[Russian Eligibility Criteria for Prescribing Menopausal Hormone Therapy to Patients With Cardiovascular and Metabolic Diseases. Consensus Document of RSC, RSOG, RAE, EUAT, RAP].
Shlyakhto EV, Sukhikh GT, Serov VN, Dedov II, Arutyunov GP, Suchkov IA, Orlova YA, Andreeva EN, Yureneva SV, Yavelov IS, Yarmolinskaya MI, Villevalde SV, Grigoryan OR, Dudinskaya EN, Ilyukhin EA, Koziolova NA, Sergienko IV, Smetnik AA, Tapilskaya NI. Shlyakhto EV, et al. Among authors: villevalde sv. Kardiologiia. 2023 Nov 8;63(10):9-28. doi: 10.18087/cardio.2023.10.n2561. Kardiologiia. 2023. PMID: 37970852 Russian.
[Russian eligibility criteria prescribing menopausal hormonal hormones therapy for patients with cardiovascular and metabolic diseases. Consensus document of the Russian Cardiological Society, Russian Society of Obstetricians and Gynecologists, Russian Association of Endocrinologists, Eurasian Association of Therapists, Association of Phlebologists of Russia].
Shlyakhto EV, Sukhikh GT, Serov VN, Dedov II, Arutyunov GP, Suchkov IA, Orlova YA, Andreeva EN, Yureneva SV, Yavelov IS, Yarmolinskaya MI, Villevalde SV, Grigoryan OR, Dudinskaya EN, Ilyukhin EA, Koziolova NA, Sergienko IV, Smetnik AA, Tapilskaya NI. Shlyakhto EV, et al. Among authors: villevalde sv. Probl Endokrinol (Mosk). 2023 Nov 12;69(5):115-136. doi: 10.14341/probl13394. Probl Endokrinol (Mosk). 2023. PMID: 37968959 Free PMC article. Russian.
[Cardiovascular effects of omega-3 polyunsaturated fatty acids: position of omega-3 polyunsaturated fatty acids in Russian and international guidelines. Council of Experts].
Mareev YV, Ezhov MV, Villevalde SV, Alieva AS, Obrezan AG, Tarasov AV, Panov AV, Konstantinov VO, Sergienko IV, Arutiunov AG, Batiushin MM, Gurevich VS, Tarlovskaya EI, Koziolova NA, Gromova OA, Orlova YA, Arutyunov GP, Mareev VY. Mareev YV, et al. Among authors: villevalde sv. Kardiologiia. 2023 Feb 28;63(2):11-18. doi: 10.18087/cardio.2023.2.n2388. Kardiologiia. 2023. PMID: 36880138 Russian.
[Empagliflozin and heart failure: position paper of the experts on the results of the online meeting and discussion of the EMPEROR-Preserved Trial].
Arutyunov GP, Lopatin YM, Ametov AS, Ageev FT, Antsiferov MB, Villevalde SV, Vinogradova NG, Galstyan GR, Galyavich AS, Gilyarevskiy SR, Glezer MG, Zhirov IV, Ilyin MV, Lebedeva AI, Nedogoda SM, Salukhov VV, Tarlovskaya EI, Tereshchenko SN, Fomin IV, Khalimov IS, Khasanov NR, Cherkashin DV, Yakushin SS. Arutyunov GP, et al. Among authors: villevalde sv. Ter Arkh. 2021 Dec 15;93(12):1491-1497. doi: 10.26442/00403660.2021.12.201281. Ter Arkh. 2021. PMID: 36286678 Russian.
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.
Pitt B, Filippatos G, Agarwal R, Anker SD, Bakris GL, Rossing P, Joseph A, Kolkhof P, Nowack C, Schloemer P, Ruilope LM; FIGARO-DKD Investigators. Pitt B, et al. N Engl J Med. 2021 Dec 9;385(24):2252-2263. doi: 10.1056/NEJMoa2110956. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449181 Clinical Trial.
Value of comparative studies of "real clinical practice" in modern cardiology. Position paper based on the expert council discussion dated 12/18/2020.
Belenkov YN, Arutunov GP, Barbarash OL, Bondareva IB, Villevalde SV, Galyavich AS, Gilarevsky SR, Duplyakov DV, Koziolova NA, Lopatin YM, Mareev YV, Martsevich SY, Panchenko EP, Fomin IV, Yavelov IS, Yakhontov DA. Belenkov YN, et al. Among authors: villevalde sv. Kardiologiia. 2021 May 31;61(5):79-81. doi: 10.18087/cardio.2021.5.n1646. Kardiologiia. 2021. PMID: 34112079 English, Russian.
57 results